Revised forecast
Fiscal year ending March 2026 · Full year (1 April 2025 to 31 March 2026)Previous forecast published Announced on 5 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Profit at each stage from core operating profit onward fell below the previously announced forecast due to the recognition of impairment losses on the Soarnol manufacturing facilities of Mitsubishi Chemical UK in Specialty Materials and the ethylene oxide and ethylene glycol manufacturing facilities of Mitsubishi Chemical in Basic Materials & Polymers, among other factors.
Impairment losses (Soarnol manufacturing facilities, ethylene oxide and ethylene glycol manufacturing facilities, etc.). Amount: Not disclosed
| Item | Details |
|---|---|
| Net Sales | 36,720 Hundreds of millions of yen → 37,040 Hundreds of millions of yen（+0.9%） |
| Operating profit | 700 Hundreds of millions of yen → 301 Hundreds of millions of yen（-57.0%） |
| Profit attributable to owners of the parent | 470 Hundreds of millions of yen → 118 Hundreds of millions of yen（-74.8%） |
| Net income per share | 34.29 yen and sen → 8.63 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year (1 April 2025 to 31 March 2026) |
| Publication date of previous forecast | Announced on 5 February 2026 |
| Previous-period results | Revenue: ¥3,947.6 billion; core operating profit: ¥228.8 billion; operating profit: ¥141.6 billion; profit for the year: ¥105.6 billion; profit for the year attributable to owners of the parent: ¥45.0 billion; basic earnings per share: ¥31.64 |
| Reason for the revision | Profit at each stage from core operating profit onward fell below the previously announced forecast due to the recognition of impairment losses on the Soarnol manufacturing facilities of Mitsubishi Chemical UK in Specialty Materials and the ethylene oxide and ethylene glycol manufacturing facilities of Mitsubishi Chemical in Basic Materials & Polymers, among other factors. |
| Details and amount of extraordinary loss | Impairment losses (Soarnol manufacturing facilities, ethylene oxide and ethylene glycol manufacturing facilities, etc.). Amount: Not disclosed |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Profit at each stage from core operating profit onward fell below the forecast due to the recognition of impairment losses on the Soarnol manufacturing facilities of Specialty Materials and the ethylene oxide and ethylene glycol manufacturing facilities of Basic Materials & Polymers, among other factors.